Relay Therapeutics, Inc.RLAYNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank71
3Y CAGR-44.5%
5Y CAGR+17.8%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-44.5%/yr
Annual compound
5Y CAGR
+17.8%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 91.18 | +77.9% |
| 2024 | 51.25 | +4.0% |
| 2023 | 49.30 | -90.7% |
| 2022 | 532.65 | -39.4% |
| 2021 | 879.64 | +2090.4% |
| 2020 | 40.16 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |